Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating dendritic cell vaccines targeting Her2/Her3 in combination with pembrolizumab for brain metastases arisi…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade [Phase 2]
Phase 2 trial investigating biomarkers to identify HER2 dependence in HER2-positive early breast cancer to de-escalate neoadjuvant chemother…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer [NA]
A clinical trial is assessing gut microbiome changes during abemaciclib therapy in breast cancer, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase III trial compares SYS6010 with chemotherapy in patients with recurrent or metastatic breast cancer that is HER2-negative and EGFR-p…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
A non-interventional prospective study conducted in Russia to assess the prevalence of BRCA1/2 mutations in early HER2-negative high-risk br…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial update evaluating Switch versus guideline-directed interventions to relieve aromatase inhibitor-related side effect…
-
CLINICAL_TRIALS other · 2026-02-12Clinical Trial Update: Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer [NA]
This clinical trial update describes a study evaluating cardiotoxicity in breast cancer patients and exploring whether exercise can reduce c…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Step by Step After Cancer [NA]
This is a completed clinical trial update for a breast cancer study (NCT02785861) sponsored by Centre Hospitalier Universitaire, Amiens. The…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study [Phase 2]
An administrative supplement update to a Phase 2 clinical trial studying how to understand and address rejection of personalized breast canc…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments [NA]
Clinical trial update describing completion of a study evaluating a FHIR-enhanced RealRisks tool to improve accuracy of breast cancer risk a…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery [NA]
This clinical trials update reports a feasibility study of the SIRA-1000 SIRA RFA electrosurgical device as an adjunct to breast-conserving …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating postoperative regional nodal radiotherapy for intermediate-risk breast cancer, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant SBRT with intratumoural pembrolizumab followed by neoadjuvant chemotherapy in breast cancer is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy [NA]
This entry notes that a trial evaluating stereotactic image-guided neoadjuvant ablative radiation followed by lumpectomy for early stage bre…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database
Ongoing multi-institution retrospective database evaluating stereotactic body radiotherapy for extracranial oligometastatic breast cancer; p…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary activity of AGX101 in adults with advanced solid tumor…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating a treatment sequence of preoperative radiotherapy, mastectomy, and immediate reconstruction for T4 breast …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX
This entry notes a clinical trial evaluating the HER2DX assay to influence treatment decisions in early-stage HER2-positive breast cancer; r…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Response-Based Local Therapy for Regionally Advanced Breast Cancer [Phase 2]
This document announces a Phase 2 clinical trial evaluating response-based local therapy for regionally advanced breast cancer. The study is…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Onvansertib + Paclitaxel In TNBC [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating the combination of onvansertib with paclitaxel in patients with triple-…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer [NA]
Feasibility study evaluating a biobehavioral stress reduction intervention for patients with breast cancer, including triple-negative breast…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer [NA]
This clinical trial, sponsored by the European Institute of Oncology, is evaluating a fasting-mimicking diet to reduce side effects of aroma…
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs [NA]
A clinical trial evaluating an individual decision aid for colorectal, breast, and ovarian cancer screening in Sweden has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Metastasis-directed Therapy for Oligometastases of Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating metastasis-directed therapy for oligometastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing Vepdegestrant (ARV-471) plus palbociclib vs letrozole plus palbociclib in ER-positive/HER2-negative advanced breast …